Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lynn T. Dengel"'
Autor:
Emily K. Ninmer, Hong Zhu, Kimberly A. Chianese-Bullock, Margaret von Mehren, Naomi B. Haas, Merrick I. Ross, Lynn T. Dengel, Craig L. Slingluff
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract The critical roles of CD4+ T cells have been understudied for cancer vaccines. Here we report long-term clinical outcomes of a randomized multicenter phase II clinical trial (NCT00118274), where patients with high-risk melanoma received a mu
Externí odkaz:
https://doaj.org/article/8ffd374f530946b7934781dedb085a13
Autor:
Annie K. Kogler, Andrew M. Polemi, Surabhi Nair, Stanislaw Majewski, Lynn T. Dengel, Craig L. Slingluff, Brian Kross, S. J. Lee, J. E. McKisson, John McKisson, Andrew G. Weisenberger, Benjamin L. Welch, Thomas Wendler, Philipp Matthies, Joerg Traub, Michael Witt, Mark B. Williams
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Background Assessment of lymphatic status via sentinel lymph node (SLN) biopsy is an integral and crucial part of melanoma surgical oncology. The most common technique for sentinel node mapping is preoperative planar scintigraphy of an injec
Externí odkaz:
https://doaj.org/article/3e0f721acbfe4a46a1e82e9ab414f315
Autor:
Joshua M. Judge, Kosta Popovic, Gina R. Petroni, Brian Kross, John McKisson, Jack McKisson, Andrew G. Weisenberger, Alexander Stolin, Stan Majewski, Patrice Rehm, Craig L. Slingluff, Mark B. Williams, Lynn T. Dengel
Publikováno v:
Journal of Surgical Research. 285:176-186
Autor:
Rick D, Vavolizza, Lynn T, Dengel
Publikováno v:
Surgical Clinics of North America. 102:1077-1087
Nipple discharge is the third most common breast-related complaint but is rarely the presenting symptom of breast cancer. Distinguishing patients with physiologic versus pathologic nipple discharge, and treating the later according to the underlying
Autor:
Craig L. Slingluff, James W. Patterson, Lynn T. Dengel, Sofia M. Shea, Donna H. Deacon, Mark E. Smolkin, Jochen T. Schaefer, Gulsun Erdag
PDF file - 118K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e5e058f7590d93b0b02d025d5cd055
https://doi.org/10.1158/0008-5472.22394826.v1
https://doi.org/10.1158/0008-5472.22394826.v1
Publikováno v:
Oncology nursing forum. 49(5)
To determine the feasibility and acceptability of using a decision aid (DA) in a breast surgery clinic.42 patients with minimally suspicious mammograms and two physicians participated in this study at an outpatient breast specialty clinic in Virginia
Autor:
Katherine M. Marsh, Courtney M. Lattimore, Christopher L. Cramer, Craig L. Slingluff, Lynn T. Dengel
Publikováno v:
Journal of surgical oncology. 126(7)
Lymphatic drainage from subcostal nodes, along the costal groove, have not previously been characterized as sites for melanoma drainage and metastasis. This study reports a series of patients with subcostal nodes draining primary melanomas, with char
Autor:
Courtney M. Lattimore, Max O. Meneveau, Katherine M. Marsh, Amber L. Shada, Craig L. Slingluff, Lynn T. Dengel
Publikováno v:
The Journal of surgical research. 278
Inguinal complete lymph node dissection (CLND) for metastatic melanoma exposes the femoral vein and artery. To protect femoral vessels while preserving the sartorius muscle, we developed a novel sartorius and adductor fascial flap (SAFF) technique fo
Autor:
Rick D Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson, Kelly T Smith, Lynn T Dengel, Kathleen Haden, William W Grosh, Varinder Kaur, Nikole Varhegyi, Elizabeth M Gaughan, Craig L Slingluff
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005424
BackgroundA vaccine containing 6 melanoma-associated peptides to stimulate helper T cells (6MHP) is safe, immunogenic, and clinically active. A phase I/II trial was designed to evaluate safety and immunogenicity of 6MHP vaccines plus programmed death
Autor:
Nadejda V. Galeassi, Caroline Reed, Varinder Kaur, Kathleen Haden, Walter C. Olson, Kimberly A. Chianese-Bullock, Anna Dickinson, Emily H. Hall, Kelly T. Smith, William W. Grosh, Nolan A. Wages, Donna H. Deacon, Gina R. Petroni, Craig L. Slingluff, Nikole Varhegyi, Mark E. Smolkin, Lynn T. Dengel, Elizabeth M. Gaughan
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)
BackgroundPeptide vaccines designed to stimulate melanoma-reactive CD4+ T cells can induce T cell and antibody (Ab) responses, associated with enhanced overall survival. We hypothesized that adding toll-like receptor 3 agonist polyICLC to an incomple